These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 9080321)
1. Gas chromatographic-mass spectrometric determination of 20(S)-protopanaxadiol and 20(S)-protopanaxatriol for study on human urinary excretion of ginsenosides after ingestion of ginseng preparations. Cui JF; Björkhem I; Eneroth P J Chromatogr B Biomed Sci Appl; 1997 Feb; 689(2):349-55. PubMed ID: 9080321 [TBL] [Abstract][Full Text] [Related]
2. Determination of aglycones of ginsenosides in ginseng preparations sold in Sweden and in urine samples from Swedish athletes consuming ginseng. Cui JF; Garle M; Björkhem I; Eneroth P Scand J Clin Lab Invest; 1996 Apr; 56(2):151-60. PubMed ID: 8743108 [TBL] [Abstract][Full Text] [Related]
3. Analysis of ginsenosides by chromatography and mass spectrometry: release of 20 S-protopanaxadiol and 20 S-protopanaxatriol for quantitation. Cui JF; Garle M; Lund E; Björkhem I; Eneroth P Anal Biochem; 1993 May; 210(2):411-7. PubMed ID: 8512077 [TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 CYP716A53v2 catalyzes the formation of protopanaxatriol from protopanaxadiol during ginsenoside biosynthesis in Panax ginseng. Han JY; Hwang HS; Choi SW; Kim HJ; Choi YE Plant Cell Physiol; 2012 Sep; 53(9):1535-45. PubMed ID: 22875608 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous quantification of twenty-one ginsenosides and their three aglycones in rat plasma by a developed UFLC-MS/MS assay: Application to a pharmacokinetic study of red ginseng. Zhou QL; Zhu DN; Yang YF; Xu W; Yang XW J Pharm Biomed Anal; 2017 Apr; 137():1-12. PubMed ID: 28086165 [TBL] [Abstract][Full Text] [Related]
6. A novel strategy for rapid quantification of 20(S)-protopanaxatriol and 20(S)-protopanaxadiol saponins in Panax notoginseng P. ginseng and P. quinquefolium. Xu FX; Yuan C; Wan JB; Yan R; Hu H; Li SP; Zhang QW Nat Prod Res; 2015; 29(1):46-52. PubMed ID: 25209869 [TBL] [Abstract][Full Text] [Related]
7. [Effect of ginseng ginsenosides on phase transitions of dipalmitoylphosphatidylcholine membranes]. Abdrasilov BS; Elemesov RE; Akoev VR; Kim IuA; Pak KhD Antibiot Khimioter; 1996 Feb; 41(2):22-9. PubMed ID: 8929114 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of triterpene saponins in ginseng drugs by high-performance liquid chromatography. Zhu S; Zou K; Cai S; Meselhy MR; Komatsu K Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):995-8. PubMed ID: 15305000 [TBL] [Abstract][Full Text] [Related]
9. American ginseng. III. Pharmacokinetics of ginsenosides in the rabbit. Chen SE; Sawchuk RJ; Staba EJ Eur J Drug Metab Pharmacokinet; 1980; 5(3):161-8. PubMed ID: 7202434 [TBL] [Abstract][Full Text] [Related]
10. Degradation of ginsenosides in humans after oral administration. Tawab MA; Bahr U; Karas M; Wurglics M; Schubert-Zsilavecz M Drug Metab Dispos; 2003 Aug; 31(8):1065-71. PubMed ID: 12867496 [TBL] [Abstract][Full Text] [Related]
11. Combination of HPLC-MS and QAMS as a new analytical approach for determination of saponins in ginseng containing products. Stavrianidi A; Stekolshchikova E; Porotova A; Rodin I; Shpigun O J Pharm Biomed Anal; 2017 Jan; 132():87-92. PubMed ID: 27697574 [TBL] [Abstract][Full Text] [Related]
12. The integration of GC-MS and LC-MS to assay the metabolomics profiling in Panax ginseng and Panax quinquefolius reveals a tissue- and species-specific connectivity of primary metabolites and ginsenosides accumulation. Liu J; Liu Y; Wang Y; Abozeid A; Zu YG; Tang ZH J Pharm Biomed Anal; 2017 Feb; 135():176-185. PubMed ID: 28038384 [TBL] [Abstract][Full Text] [Related]
13. Main ginseng saponin metabolites formed by intestinal bacteria. Hasegawa H; Sung JH; Matsumiya S; Uchiyama M Planta Med; 1996 Oct; 62(5):453-7. PubMed ID: 8923812 [TBL] [Abstract][Full Text] [Related]
14. American ginseng. II. Analysis of ginsenosides and their sapogenins in biological fluids. Chen SE; Staba EJ J Nat Prod; 1980; 43(4):463-6. PubMed ID: 7431024 [TBL] [Abstract][Full Text] [Related]
15. Marked production of ginsenosides Rd, F2, Rg3, and compound K by enzymatic method. Ko SR; Suzuki Y; Suzuki K; Choi KJ; Cho BG Chem Pharm Bull (Tokyo); 2007 Oct; 55(10):1522-7. PubMed ID: 17917300 [TBL] [Abstract][Full Text] [Related]
16. Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta. Kang SY; Schini-Kerth VB; Kim ND Life Sci; 1995; 56(19):1577-86. PubMed ID: 7723586 [TBL] [Abstract][Full Text] [Related]
18. [Action of triterpene glycosides of the dammarane series and their aglycones on the K+ and H+ ion currents in erythrocytes, induced by the ionophore A23187 and divalent ions]. Kim IuA; Abdrasilov BS; Nurieva RI; Pak KhD Antibiot Khimioter; 1995; 40(11-12):20-4. PubMed ID: 8830634 [TBL] [Abstract][Full Text] [Related]
19. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. Shibata S J Korean Med Sci; 2001 Dec; 16 Suppl(Suppl):S28-37. PubMed ID: 11748374 [TBL] [Abstract][Full Text] [Related]
20. Combination of HPLC and 252-Cf plasma desorption mass spectrometry for identifying composition of ginseng tinctures. Elkin YN; Makhankov VV; Uvarova NL; Bondarenko PV; Zubarev RA; Knysh AN Zhongguo Yao Li Xue Bao; 1993 Mar; 14(2):97-100. PubMed ID: 8352021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]